ACKR4 ( non-phospho ), Atypical Chemokine Receptor 4 Polyclonal Antibody

ACKR4 ( non-phospho ), Atypical Chemokine Receptor 4 Polyclonal Antibody

Catalog Number:
A001455946TMA
Mfr. No.:
7TM0315N
Price:
$528
  • Size:
    100 µl
    Quantity:
    Add to Cart:
      • Overview
        • The ACKR4 receptor antibody is directed against the distal end of the carboxyl-terminal tail of human Atypical Chemokine Receptor 4. It can be used to detect total ACKR4 receptors in Western blots independent of phosphorylation. The ACKR4 antibody can also be used to detect ACKR4 in formalin-fixed, paraffin-embedded tissue sections by immunohistochemistry.

          Please contact us at for specific academic pricing.

      • Properties
        • Host
          rabbit
          Antibody Type
          polyclonal
          Isotype
          IgG
          Reactivity
          human
          Immunogen
          A synthetic peptide presents distal end of carboxyl-terminal tail of human ACKR4.
          Purification
          Antigen affinity chromatography
          Formulation
          Liquid
          Storage
          Short-term storage at 4°C and long-term storage at -20°C
          Antigen
          ACKR4, Atypical Chemokine Receptor 4 (UniProt:Q9NPB9)

          * This product is intended for research use only.

      • Applications
        • Application
          WB; IHC
        • Application Dilutions
          Western Blot (WB) 1:1000
          Immunohistochemistry (IHC) 1:100
      • Reference
        • Schulz S, Pauli SU, Schulz S, Händel M, Dietzmann K, Firsching R, Höllt V. Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clin Cancer Res. 2000 May;6(5):1865-74.
          Asnacios A, Courbon F, Rochaix P, Bauvin E, Cances-Lauwers V, Susini C, Schulz S, Boneu A, Guimbaud R, Buscail L. Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors. J Clin Oncol. 2008 Feb 20;26(6):963-70. doi: 10.1200/JCO.2007.12.7431.
          Fischer T, Doll C, Jacobs S, Kolodziej A, Stumm R, Schulz S. Reassessment of sst2 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-1. J Clin Endocrinol Metab. 2008 Nov;93(11):4519-24. doi: 10.1210/jc.2008-1063. Epub 2008 Aug 12.
          Lesche S, Lehmann D, Nagel F, Schmid HA, Schulz S. Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro. J Clin Endocrinol Metab. 2009 Feb;94(2):654-61. doi: 10.1210/jc.2008-1919. Epub 2008 Nov 11.
          Shi TJ, Xiang Q, Zhang MD, Barde S, Kai-Larsen Y, Fried K, Josephson A, Glück L, Deyev SM, Zvyagin AV, Schulz S, Hökfelt T. Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human: expression, trafficking and possible role in pain. Mol Pain. 2014 Feb 13;10:12. doi: 10.1186/1744-8069-10-12. PubMed PMID: 24521084; PubMed Central PMCID: PMC3943448.

    Note: If you don't receive our verification email, do the following:

  • Copyright © Amerigo Scientific. All rights reserved.